BillionToOne

About BillionToOne

BillionToOne is a company focused on molecular testing with a proprietary technology called Quantitative Counting Templates (QCTs™), which detects and quantifies disease at a single base-pair level. Their mission is to make molecular testing more accurate, efficient, and accessible, aiming to improve healthcare by detecting disease one molecule at a time. They target prenatal screening and oncology testing to help patients through advanced disease detection.

Products & Services

UNITY Complete®:A prenatal screening test that includes a carrier screen, single-gene testing for recessive conditions, and aneuploidy NIPT, assessing fetal risk from maternal blood at 9+ weeks.

Northstar Select™:An oncology test that helps determine the most appropriate first-line therapy for cancer patients.

UNITY Screen

Northstar Select

Northstar Response

UNITY Confirm

Specialties

Molecular Testing Prenatal Screening Oncology Testing Disease Detection at Single Base-Pair Level Quantitative Counting Templates (QCTs™) Single-molecule NGS (smNGS) Prenatal genetic screening Liquid biopsy oncology testing Cell-free DNA quantification

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: IPO T: - FT: IPO	A: 314000000 MR: - FA: approximately $314.0 million FAN: 314000000	D: 2025-11-07 FD: 2025-11-07	7 investors
2	RT: IPO T: - FT: IPO	A: 273100000 MR: - FA: 273.1 million FAN: 273100000	D: 2025-11-06 FD: 2025-11-06	7 investors
3	RT: Non-Dilutive Financing T: - FT: Non-Dilutive Financing	A: 140000000 MR: - FA: $140 million FAN: 140000000	D: 2024-09-04 FD: 2024-09-04	1 investors
4	RT: Series D T: - FT: Series D	A: 130000000 MR: - FA: $130 million FAN: 130000000	D: 2024-06-21 FD: 2024-06-21	8 investors

IPO Latest

2025-11-07

$314.0M

7 investors (Pro only)

IPO 2025-11-06

$273.1M

Non-Dilutive Financing 2024-09-04

$140.0M

View 3 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

A

Allen Chen

Vice President of Medical Affairs and Clinical Development, Oncology

O

Oguzhan Atay, PhD

Co-Founder, CEO, and Board Chair

D

David Tsao, PhD

Co-Founder, CTO, and Board Member

R

Ross Taylor, MBA

Chief Financial Officer

S

Shan Riku, MBA

Chief Product Officer

J

John Lister

Chief Administrative Officer

View 49 more team members with Pro

Unlock Full Team Directory

Recent News

BillionToOne Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised